KEGG   PATHWAY: ocu05225
Entry
ocu05225                    Pathway                                
Name
Hepatocellular carcinoma - Oryctolagus cuniculus (rabbit)
Description
Hepatocellular carcinoma (HCC) is a major type of primary liver cancer and one of the rare human neoplasms etiologically linked to viral factors. It has been shown that, after HBV/HCV infection and alcohol or aflatoxin B1 exposure, genetic and epigenetic changes occur. The recurrent mutated genes were found to be highly enriched in multiple key driver signaling processes, including telomere maintenance, TP53, cell cycle regulation, the Wnt/beta-catenin pathway (CTNNB1 and AXIN1), the phosphatidylinositol-3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway. Recent studies using whole-exome sequencing have revealed recurrent mutations in new driver genes involved in the chromatin remodelling (ARID1A and ARID2) and the oxidative stress (NFE2L2) pathways.
Class
Human Diseases; Cancer: specific types
Pathway map
ocu05225  Hepatocellular carcinoma
ocu05225

Disease
H00048  Hepatocellular carcinoma
Organism
Oryctolagus cuniculus (rabbit) [GN:ocu]
Gene
100008645  TGFB1; transforming growth factor beta-1 proprotein [KO:K13375]
100008806  [KO:K04361] [EC:2.7.10.1]
100008822  [KO:K05692]
100008875  BCL2L1; bcl-2-like protein 1 [KO:K04570]
100008879  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
100008919  [KO:K00510] [EC:1.14.14.18]
100009030  WNT11; protein Wnt-11 [KO:K01384]
100009033  [KO:K00312]
100009039  [KO:K02089] [EC:2.7.11.22]
100009040  [KO:K02091] [EC:2.7.11.22]
100009073  GSTM2; glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
100009102  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
100009227  CSNK1A1; casein kinase I isoform alpha [KO:K08957] [EC:2.7.11.1]
100009260  RPS6KB1; ribosomal protein S6 kinase beta-1 [KO:K04688] [EC:2.7.11.1]
100009272  ACTB; actin, cytoplasmic 1 [KO:K05692]
100009292  TP53; cellular tumor antigen p53 [KO:K04451]
100009316  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100009371  TGFB2; transforming growth factor beta-2 proprotein precursor [KO:K13376]
100009381  WNT5A; protein Wnt-5a precursor [KO:K00444]
100009482  [KO:K08774]
100009566  [KO:K03068]
100037719  PRKCB; protein kinase C beta type isoform I [KO:K19662] [EC:2.7.11.13]
100037720  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100125985  [KO:K02105]
100126565  MET; hepatocyte growth factor receptor precursor [KO:K05099] [EC:2.7.10.1]
100126569  WNT2; protein Wnt-2 precursor [KO:K00182]
100144342  [KO:K05087] [EC:2.7.10.1]
100303773  [KO:K00408]
100316908  HGF; hepatocyte growth factor precursor [KO:K05460]
100327265  MYC; myc proto-oncogene protein [KO:K04377]
100328792  IGF2; insulin-like growth factor II precursor [KO:K13769]
100328910  [KO:K00799] [EC:2.5.1.18]
100328911  [KO:K00799] [EC:2.5.1.18]
100337822  [KO:K00922] [EC:2.7.1.153]
100337904  [KO:K08957] [EC:2.7.11.1]
100338194  [KO:K00799] [EC:2.5.1.18]
100338449  [KO:K00799] [EC:2.5.1.18]
100338581  [KO:K11340]
100338684  [KO:K11651]
100339216  [KO:K02620]
100339222  [KO:K11650]
100339336  [KO:K02353]
100339544  [KO:K02329]
100339765  [KO:K04385]
100339842  [KO:K00799] [EC:2.5.1.18]
100339996  [KO:K00799] [EC:2.5.1.18]
100340139  [KO:K05859] [EC:3.1.4.11]
100340437  [KO:K08845] [EC:2.7.11.1]
100340471  [KO:K04490]
100340625  [KO:K06621]
100340711  [KO:K00799] [EC:2.5.1.18]
100340829  [KO:K00799] [EC:2.5.1.18]
100340952  [KO:K04375]
100340967  [KO:K00799] [EC:2.5.1.18]
100341037  [KO:K05692]
100341104  [KO:K00799] [EC:2.5.1.18]
100341622  [KO:K00799] [EC:2.5.1.18]
100342046  [KO:K14021]
100342099  [KO:K02354]
100342268  [KO:K23790]
100342294  [KO:K04501]
100342500  [KO:K04364]
100342812  [KO:K06279]
100342852  [KO:K04456] [EC:2.7.11.1]
100342870  [KO:K00714]
100343712  [KO:K11649]
100343715  [KO:K00355] [EC:1.6.5.2]
100344241  [KO:K07828]
100344334  [KO:K11653]
100344335  TGFBR2; TGF-beta receptor type-2 precursor [KO:K04388] [EC:2.7.11.30]
100344394  [KO:K02376]
100344508  [KO:K22198]
100345181  [KO:K00922] [EC:2.7.1.153]
100345250  [KO:K02649]
100345503  [KO:K08957] [EC:2.7.11.1]
100345555  [KO:K22197]
100345769  [KO:K11650]
100345803  [KO:K02842]
100345812  [KO:K04674] [EC:2.7.11.30]
100346125  [KO:K09593]
100346303  [KO:K23605]
100346379  [KO:K09389]
100346391  [KO:K03099]
100346935  [KO:K10456]
100347345  [KO:K04371] [EC:2.7.11.24]
100347407  [KO:K04366] [EC:2.7.11.1]
100347453  [KO:K11647] [EC:5.6.2.-]
100347487  [KO:K07827]
100347818  [KO:K11757]
100348127  [KO:K02157]
100348489  [KO:K06625]
100348561  [KO:K04371] [EC:2.7.11.24]
100348581  [KO:K08957] [EC:2.7.11.1]
100348663  [KO:K00922] [EC:2.7.1.153]
100348842  [KO:K03083] [EC:2.7.11.26]
100348986  [KO:K00445]
100349021  [KO:K00799] [EC:2.5.1.18]
100349069  [KO:K22198]
100349579  [KO:K00444]
100349847  [KO:K00182]
100349958  [KO:K01116] [EC:3.1.4.11]
100350037  [KO:K11650]
100350521  [KO:K02235]
100350676  [KO:K17449]
100350883  [KO:K11648]
100351316  [KO:K01357]
100351964  [KO:K04365] [EC:2.7.11.1]
100352000  [KO:K03068]
100352218  [KO:K03511] [EC:2.7.7.7]
100352227  [KO:K01064]
100352301  [KO:K13375]
100352386  [KO:K10140]
100352479  [KO:K08957] [EC:2.7.11.1]
100352691  [KO:K04492]
100352839  [KO:K01357]
100352919  [KO:K02375]
100353014  [KO:K05638]
100353090  [KO:K01558]
100353173  [KO:K06620]
100353174  [KO:K00799] [EC:2.5.1.18]
100353284  [KO:K04402]
100353428  [KO:K00799] [EC:2.5.1.18]
100353559  [KO:K01064]
100353681  [KO:K00799] [EC:2.5.1.18]
100353706  [KO:K04456] [EC:2.7.11.1]
100353742  [KO:K04402]
100353758  [KO:K11651]
100353776  [KO:K11649]
100353927  [KO:K00799] [EC:2.5.1.18]
100353976  [KO:K02085]
100353992  [KO:K17448]
100354018  [KO:K03209]
100354040  [KO:K11653]
100354186  [KO:K00799] [EC:2.5.1.18]
100354391  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X1 [KO:K22182] [EC:1.8.1.9]
100354436  [KO:K00799] [EC:2.5.1.18]
100354583  [KO:K00312]
100355675  [KO:K02159]
100355697  [KO:K00572]
100356052  [KO:K00799] [EC:2.5.1.18]
100356164  [KO:K07203] [EC:2.7.11.1]
100356179  TXNRD1; thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
100356196  [KO:K08957] [EC:2.7.11.1]
100356368  [KO:K02432]
100356615  [KO:K03099]
100356957  [KO:K17454]
100357059  [KO:K11652]
100357102  [KO:K11723]
100357148  [KO:K00799] [EC:2.5.1.18]
100357431  [KO:K06618]
100357841  [KO:K02649]
100357917  [KO:K00799] [EC:2.5.1.18]
100357933  [KO:K00714]
100358177  [KO:K00799] [EC:2.5.1.18]
100358257  TXNRD3; thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
100358367  [KO:K02353]
100358378  [KO:K04491]
100358587  [KO:K02158]
100358681  [KO:K11765]
100358716  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
100358982  [KO:K13377]
100359137  [KO:K04500]
103345448  [KO:K13375]
103346018  [KO:K02085]
103348917  [KO:K02432]
103350707  [KO:K00799] [EC:2.5.1.18]
103351400  [KO:K03069]
103352372  [KO:K02375]
108176675  [KO:K22182] [EC:1.8.1.9]
108178409  [KO:K03096]
127484730  [KO:K04688] [EC:2.7.11.1]
127485674  [KO:K02085]
127486116  [KO:K04456] [EC:2.7.11.1]
127486605  [KO:K02833]
127488791  [KO:K22197]
127489175  [KO:K17454]
127489236  [KO:K07827]
127489271  [KO:K02353]
127489461  [KO:K04368] [EC:2.7.12.2]
127490035  [KO:K00799] [EC:2.5.1.18]
127491145  [KO:K11649]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00165  Diacylglycerol
C00533  Nitric oxide
C00704  Superoxide
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C06793  Vinyl chloride
C06800  Aflatoxin B1
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Whittaker S, Marais R, Zhu AX
  Title
The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
  Journal
Oncogene 29:4989-5005 (2010)
DOI:10.1038/onc.2010.236
Reference
  Authors
Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM
  Title
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
  Journal
Gastroenterology 149:1226-1239.e4 (2015)
DOI:10.1053/j.gastro.2015.05.061
Reference
  Authors
Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM.
  Title
Genomics and signaling pathways in hepatocellular carcinoma.
  Journal
Semin Liver Dis 27:55-76 (2007)
DOI:10.1055/s-2006-960171
Reference
  Authors
Breuhahn K, Longerich T, Schirmacher P
  Title
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
  Journal
Oncogene 25:3787-800 (2006)
DOI:10.1038/sj.onc.1209556
Reference
  Authors
Minguez B, Tovar V, Chiang D, Villanueva A, Llovet JM
  Title
Pathogenesis of hepatocellular carcinoma and molecular therapies.
  Journal
Curr Opin Gastroenterol 25:186-94 (2009)
DOI:10.1097/MOG.0b013e32832962a1
Reference
  Authors
Kudo M
  Title
Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
  Journal
Dig Dis 29:289-302 (2011)
DOI:10.1159/000327562
Reference
  Authors
Nault JC, Zucman-Rossi J
  Title
Genetics of hepatocellular carcinoma: the next generation.
  Journal
J Hepatol 60:224-6 (2014)
DOI:10.1016/j.jhep.2013.08.019
Reference
  Authors
Rocken C, Carl-McGrath S.
  Title
Pathology and pathogenesis of hepatocellular carcinoma.
  Journal
Dig Dis 19:269-78 (2001)
DOI:10.1159/000050693
Reference
  Authors
Cornella H, Alsinet C, Villanueva A
  Title
Molecular pathogenesis of hepatocellular carcinoma.
  Journal
Alcohol Clin Exp Res 35:821-5 (2011)
DOI:10.1111/j.1530-0277.2010.01406.x
Reference
  Authors
Niu ZS, Niu XJ, Wang WH
  Title
Genetic alterations in hepatocellular carcinoma: An update.
  Journal
World J Gastroenterol 22:9069-9095 (2016)
DOI:10.3748/wjg.v22.i41.9069
Reference
  Authors
Tannapfel A, Wittekind C
  Title
Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.
  Journal
Virchows Arch 440:345-52 (2002)
DOI:10.1007/s00428-002-0617-x
Reference
  Authors
Shiraha H, Yamamoto K, Namba M
  Title
Human hepatocyte carcinogenesis (review).
  Journal
Int J Oncol 42:1133-8 (2013)
DOI:10.3892/ijo.2013.1829
Reference
  Authors
Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J
  Title
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
  Journal
Nat Commun 4:2218 (2013)
DOI:10.1038/ncomms3218
Reference
  Authors
Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clement B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouze E, Calvo F, Zucman-Rossi J
  Title
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
  Journal
Nat Genet 44:694-8 (2012)
DOI:10.1038/ng.2256
Reference
  Authors
Praslicka BJ, Kerins MJ, Ooi A
  Title
The complex role of NRF2 in cancer: a genomic view
  Journal
Curr Opin Toxicol 1:37-45 (2016)
DOI:10.1016/j.cotox.2016.09.003
Reference
  Authors
Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL
  Title
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer.
  Journal
Redox Biol 1:45-9 (2013)
DOI:10.1016/j.redox.2012.10.001
Reference
  Authors
Taguchi K, Motohashi H, Yamamoto M
  Title
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution.
  Journal
Genes Cells 16:123-40 (2011)
DOI:10.1111/j.1365-2443.2010.01473.x
Reference
  Authors
Klaunig JE, Kamendulis LM, Hocevar BA
  Title
Oxidative stress and oxidative damage in carcinogenesis.
  Journal
Toxicol Pathol 38:96-109 (2010)
DOI:10.1177/0192623309356453
Reference
  Authors
Krupp G, Bonatz G, Parwaresch R
  Title
Telomerase, immortality and cancer.
  Journal
Biotechnol Annu Rev 6:103-40 (2000)
DOI:10.1016/S1387-2656(00)06020-8
Reference
  Authors
Jafri MA, Ansari SA, Alqahtani MH, Shay JW
  Title
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
  Journal
Genome Med 8:69 (2016)
DOI:10.1186/s13073-016-0324-x
Reference
  Authors
Shay JW
  Title
Role of Telomeres and Telomerase in Aging and Cancer.
  Journal
Cancer Discov 6:584-93 (2016)
DOI:10.1158/2159-8290.CD-16-0062
Reference
  Authors
Granito A, Guidetti E, Gramantieri L
  Title
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
  Journal
J Hepatocell Carcinoma 2:29-38 (2015)
DOI:10.2147/JHC.S77038
Reference
  Authors
Vita M, Henriksson M
  Title
The Myc oncoprotein as a therapeutic target for human cancer.
  Journal
Semin Cancer Biol 16:318-30 (2006)
DOI:10.1016/j.semcancer.2006.07.015
Reference
  Authors
Qu A, Jiang C, Cai Y, Kim JH, Tanaka N, Ward JM, Shah YM, Gonzalez FJ
  Title
Role of Myc in hepatocellular proliferation and hepatocarcinogenesis.
  Journal
J Hepatol 60:331-8 (2014)
DOI:10.1016/j.jhep.2013.09.024
Related
pathway
ocu04010  MAPK signaling pathway
ocu04020  Calcium signaling pathway
ocu04110  Cell cycle
ocu04115  p53 signaling pathway
ocu04151  PI3K-Akt signaling pathway
ocu04310  Wnt signaling pathway
ocu04350  TGF-beta signaling pathway
ocu04932  Non-alcoholic fatty liver disease
ocu04936  Alcoholic liver disease
ocu05160  Hepatitis C
ocu05161  Hepatitis B
KO pathway
ko05225   

DBGET integrated database retrieval system